Most Popular Stories
- DNA sequencing exposes new uses for Pfizer targeted cancer drugs
- Preclinical study triggers 'massive response' from desperate Alzheimer's patients
- Ben Venue's idled plant triggers 'dire' leukemia-drug shortage
- GSK, Takeda say nay to in-house diagnostics units
- Gene study finds tumor-cell flaw possibly vulnerable to Pfizer, AZ cancer meds
- Hungry Valeant snags Eyetech in ongoing buyout spree
- GSK studies Chinese remedies to discover new drugs
- Chelsea shares nosedive on FDA's questions about key drug
- DNA sequencing exposes new uses for Pfizer targeted cancer drugs
- Preclinical study triggers 'massive response' from desperate Alzheimer's patients
- Hungry Valeant snags Eyetech in ongoing buyout spree
Webinars
- Special Studies in Cancer Patients: AME and Cardiac SafetyFierceBiotech Editor John Carroll will moderate an expert panel discussion exploring how c
- Inside the mHealth Revolution with Welch Allyn: Realizing the Potential of Connected DevicesAfter launching a line of connected devices, Welch Allyn immediately viewed it as an oppor
- Prepare Your Compliance Systems and Processes for the Physician Payments Sunshine ActBeginning in 2012, pharmaceutical, biotechnology and medical device companies will be requ
- Drug Development: An Overview of the Regulated Clinical Trials Process Used to Bring a New Drug to MarketJoin us for a one-hour overview of the regulated clinical trials process used to bring a n
Featured Jobs
-
Facilities Project Manager
Genomics Institute of the Novartis Research Foundation - San Diego, CA -
Associate Manager, Global Supply Chain Planning (1 of 3) Job
Celgene Corporation - Basking Ridge, NJ, US -
Director, Global Regulatory CMC Job
Celgene Corporation - Basking Ridge, NJ, US -
Program Lead - Scientific Information Architecture & Search
Merck - Kenilworth, NJ -
District Sales Manager – Hematology, Denver / Phoenix Job
Celgene Corporation - Denver, CO, US
Events
- Pharmaceutical Strategic Outlook
April 11-13, 2012 — Grand Hyatt, New York - Pharmaceutical Strategic Outlook
April 11-13, 2012 - Euro-Biotech Partnering Summit
May 30-June 1, 2012 — Paris, France - World Orphan Drug Congress USA 2012
10-13 April, 2012 — Gaylord National Resort and Convention Center, Washington, D.C.
Free Newsletter
FierceBiotech is the biotech industry's daily monitor, with a special focus on drug discovery and clinical trials. Keep up to speed with the latest biotechnology trends, breakthroughs and FDA approval news. Join 90,000+ biotechnology and pharma industry professionals who get FierceBiotech via daily email. Sign up today!
Popular Topics
Whitepapers
- Displacement Chromatography Comes of Age - An indispencable tool for the purification of biomacromolecules
- Niche Tourism Beginning and digital marketing : Beginning of the future?
- The 3W Gaurrantee: What you Really Saved when you invest in Outsourced Talent
- Avoiding Post-Acquisition Product Sales Failures
- Tar Heel Biotech: The Policies, Trends, and Investments That Continue to Promote Growth in North Carolina's Biotechnology Sector
- API in Capsule: Common "First in Man" approaches vs. The Lost Art of Formulation Development
Harvey Berger, Ariad Pharmaceuticals CEO
